dc.contributor.author |
Sidani, Mazen Moustafa |
dc.date.accessioned |
2012-06-13T07:05:43Z |
dc.date.available |
2012-06-13T07:05:43Z |
dc.date.issued |
2002 |
dc.identifier.uri |
http://hdl.handle.net/10938/6256 |
dc.description |
Thesis (M.S.)--Dept.of Biology, AUB, 2002.;"Advisor: Dr. Hala Mohtaseb, Associate Professor, Biology--Member of Committee: Dr. Nadine Darwiche, Associate Professor, Biology--Member of Committee: Dr. Marwan El-Sabban, Associate Professor, Human Morphology- |
dc.description |
Bibliography : leaves 108-121. |
dc.description.abstract |
The resistance of hypoxic tumor cells to radiotherapy and chemotherapy has led to the design of hypoxia-selective agents that can potentiate ionizing radiation (IR)- induced tumor cell kill. Hypoxic cells are known to induce several tumorigenic-triggered |
dc.format.extent |
xvii, 121 leaves : ill., tables. |
dc.language.iso |
eng |
dc.relation.ispartof |
Theses, Dissertations, and Projects |
dc.subject.classification |
T:004320 AUBNO |
dc.subject.lcsh |
Neovascularization inhibitors |
dc.subject.lcsh |
Cancer cells -- Growth -- Regulation |
dc.subject.lcsh |
Cancer -- Prevention |
dc.subject.lcsh |
Quinoxaline |
dc.subject.lcsh |
Dioxide |
dc.subject.lcsh |
Hypoxia -- Pathophysiology |
dc.title |
Quinoxaline 1,4-dioxides novel angiogenesis inhibitors that potentiate the antitumor effects of ionizing radiation by sensitizing hypoxic tumor cells - by Mazen Moustafa Sidani |
dc.type |
Thesis |
dc.contributor.department |
American University of Beirut. Faculty of Arts and Sciences. Department of Biology |